Business
Linux Laboratories raises $70 million from ChrysCapital
Livemint··30 Sept
Chennai-based Linux Laboratories raised $70 million from ChrysCapital and Tata Capital Healthcare Fund III, the company said Wednesday. ChrysCapital took a significant minority stake via primary capital and a secondary sale that delivered about 4x returns for Tata Capital Healthcare Fund II. Linux runs over 125 brands across roughly 400 stock-keeping units in central nervous system therapies.
Prism
What It Means For You
- Chronic therapy brands under Linux may expand prescriber reach as fresh capital lands.
- Investors continue backing domestic formulations platforms as chronic disease burdens rise.
- Secondary sales let earlier Tata healthcare fund investors exit while Fund III reinvests.
What's Happening
- Avendus advised a raise first reported by Mint in January at up to $70 million.
- Founders Hariharan, Keerthivasan and Ananda Kumar built Linux since 2007 in Chennai.
- The firm also operates a WHO-GMP plant supporting exports and contract manufacturing.
Speciality pharma capital cycle
- India's branded formulations market draws private equity as speciality portfolios grow.
- Linux extended from CNS into dermatology, cardio-diabetics and nutraceuticals.
- ChrysCapital cited M&A track record among reasons for backing the platform.
all-news
